D Robinson, R Abdulkareem, D Nasrollah… - JAMA Network …, 2023 - jamanetwork.com
Importance In randomized clinical trials (RCTs), magnetic resonance imaging (MRI) before prostate biopsy has been associated with fewer biopsies, decreased detection of Gleason …
Background Three primary strategies for MRI-targeted biopsies (TB) are available: Cognitive TB (COG-TB), MRI-US Fusion TB (FUS-TB), and In Bore TB (IB-TB). Despite nearly a decade …
K Ho, D Zhu, K Gupta, J Loloi, M Abramson… - … Oncology: Seminars and …, 2024 - Elsevier
Purpose Transrectal ultrasound-guided prostate biopsy remains the most used method for the detection of prostate cancer. We recently reported that detection of clinically significant …
R Deng, Y Liu, K Wang, M Ruan, D Li, J Wu, J Qiu… - BMC medicine, 2024 - Springer
Background Cognitive fusion MRI-guided targeted biopsy (cTB) has been widely used in the diagnosis of prostate cancer (PCa). However, cTB relies heavily on the operator's …
M Ito, I Yonese, M Toide, S Ikuta, S Kobayashi… - International Journal of …, 2023 - Springer
Abstract Background The BioJet system allows the fusion of magnetic resonance imaging (MRI) images with real-time transrectal ultrasonography to accurately direct biopsy needles …
CC Zhao, JK Rossi, JS Wysock - Urology, 2023 - Elsevier
Objective To evaluate the cancer detection rate (CDR) between the 2 dominant spatial tracking methodologies in software-guided MRI-transrectal ultrasound fusion prostate biopsy …
A Llewellyn, TH Phung, MO Soares… - Health Technology …, 2024 - pmc.ncbi.nlm.nih.gov
BACKGROUND Magnetic resonance imaging localises cancer in the prostate, allowing for a targeted biopsy with or without transrectal ultrasound-guided systematic biopsy. Targeted …
AE Ross, A Lazarovich, AS Dahmen, A Sidana, J Millot… - Rev Urol, 2024 - researchgate.net
The diagnosis of prostate cancer (PCa) has changed substantially over the last decade. An increased understanding of disease behavior has led to the development of more specific …